Kovack Advisors’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.27M Buy
283,986
+30,600
+12% +$300K 0.16% 128
2026
Q1
$1.72M Buy
253,386
+105,023
+71% +$946K 0.09% 221
2025
Q4
$1.59M Buy
148,363
+13,058
+10% +$143K 0.07% 251
2025
Q3
$1.69M Buy
135,305
+25,320
+23% +$259K 0.16% 124
2025
Q2
$1.12M Buy
109,985
+69,130
+169% +$608K 0.11% 182
2025
Q1
$323K Buy
40,855
+6,255
+18% +$77K 0.03% 405
2024
Q4
$272K Sell
34,600
-59,650
-63% -$299K 0.03% 477
2024
Q3
$297K Sell
94,250
-7,900
-8% -$23.2K 0.03% 440
2024
Q2
$289K Buy
102,150
+59,500
+140% +$424K 0.03% 426
2024
Q1
$672K Buy
42,650
+12,100
+40% +$205K 0.08% 208
2023
Q4
$601K Buy
30,550
+20,300
+198% +$353K 0.07% 261
2023
Q3
$209K Buy
+10,250
New +$258K 0.03% 475

Other funds holding CRNC

Kovack Advisors's CRNC Position: Q2 2026 in Review

Kovack Advisors increased its Cerence (CRNC) stake by 12% in Q2 2026, buying an estimated $300K and bringing the position to 283,986 shares worth $3.27M. The position accounts for 0.16% of the portfolio, ranked #128.

Kovack Advisors first reported a position in CRNC in Q3 2023 and has held it in 12 quarters since. 194 funds tracked by Wall St. Rank hold CRNC as of Q2 2026.

  • Kovack Advisors held 283,986 shares of Cerence worth $3.27M as of Q2 2026.
  • Kovack Advisors bought 30,600 Cerence shares in Q2 2026, an estimated $300K.
  • Cerence made up 0.16% of Kovack Advisors's portfolio in Q2 2026, its #128 holding.
  • Kovack Advisors first reported a position in Cerence in Q3 2023 and has held it in 12 quarters since.
  • 194 funds tracked by Wall St. Rank held Cerence as of Q2 2026.

Based on Kovack Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.